Stock Report

Astec LifeSciences Ltd consolidated Q1FY26 loss at Rs. 33.03 crores

Posted On : 2025-07-28 20:23:14( TIMEZONE : IST )

Astec LifeSciences Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 91.5886 crores during the period ended June 30, 2025 as compared to Rs. 120.3182 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. -33.0378 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. -16.0876 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. -16.85 for the period ended June 30, 2025 as compared to Rs. -8.20 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 91.5886 crs	₹120.3182 crs	-23.88%
Net Profit	₹-33.0378 crs	₹-16.0876 crs	105.36%
EPS	₹-16.85	₹-8.20	105.49%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 91.5886 crores during the period ended June 30, 2025 as compared to Rs.70.2962 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.-33.0378 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.-39.7246 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.-16.85 for the period ended June 30, 2025 as compared to Rs.-20.26 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 91.5886 crs	₹70.2962 crs	30.29%
Net Profit	₹-33.0378 crs	₹-39.7246 crs	16.83%
EPS	₹-16.85	₹-20.26	16.83%

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 869.45 as compared to the previous close of Rs. 900.10. The total number of shares traded during the day was 4420 in over 510 trades.

The stock hit an intraday high of Rs. 923.75 and intraday low of 836.50. The net turnover during the day was Rs. 3933346.00.